Bruce C. Cozadd - 16 Jan 2026 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Role
Director
Signature
Bruce C Cozadd
Issuer symbol
JAZZ
Transactions as of
16 Jan 2026
Net transactions value
-$2,987,255
Form type
4
Filing time
21 Jan 2026, 19:16:13 UTC
Previous filing
01 Dec 2025
Next filing
04 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
COZADD BRUCE C Director 5TH FL, WATERLOO EXCHANGE, WATERLOO RD, DUBLIN 4, IRELAND Bruce C Cozadd 21 Jan 2026 0001193210

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAZZ Ordinary Shares Award $0 +35,917 +9.1% $0.000000 429,249 16 Jan 2026 Direct F1
transaction JAZZ Ordinary Shares Tax liability $2,987,255 -17,453 -4.1% $171.16 411,796 16 Jan 2026 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents ordinary shares of the Issuer delivered pursuant to the terms of performance share awards made to the reporting person on March 3, 2023. The performance-based vesting requirements applicable to such awards were satisfied on January 16, 2026, which represents the date on which the level of performance attained was certified.
F2 Shares withheld from the vesting and distribution of performance share awards to satisfy the reporting person's tax obligations.